Learning to experience side effects after antidepressant intake – Results from a randomized, controlled, double-blind study
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Side effects play a key role in patients' failure to take antidepressants. There is evidence that verbal suggestions and informed consent elicit expectations that can in turn trigger the occurrence of side effects. Prior experience or learning mechanisms are also assumed to contribute to the development of side effects, although their role has not been thoroughly investigated. In this study, we examined whether an antidepressant's side effects can be learned via Pavlovian conditioning. METHODS: Participants (n = 39) were randomly allocated to one of two groups and were exposed to a classical conditioning procedure. During acquisition, 19 participants received amitriptyline and 20 participants received a placebo pill. Pills were taken for four nights together with a novel-tasting drink. After a washout phase, both groups received a placebo pill together with the novel-tasting drink (evocation). Side effects were assessed via the Generic Assessment of Side Effects Scale prior to acquisition (baseline), after acquisition, and after evocation. A score of antidepressant-specific side effects was calculated. RESULTS: Participants taking amitriptyline reported significantly more antidepressant-specific side effects after acquisition compared to both baseline and the placebo group. After evocation, participants who underwent the conditioning procedure with amitriptyline reported significantly more antidepressant-specific side effects than those who never received amitriptyline, even though both groups received a placebo. CONCLUSIONS: Our results indicate that antidepressant side effects can be learned using a conditioning paradigm and evoked via a placebo pill when applied with the same contextual factors as the verum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Multiple recurrences of major depressive disorder
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.229 · Cited by 835 · cited 1×
“This result is highly relevant, since patients suffering from depression often experience several depressive episodes in their lives and usually undergo repeated pharmacological treatment (Solomon and Keller 2000).”
BackgroundNonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · cited 3×
“These rates are alarming, considering that guidelines suggest taking antidepressant medication for at least 6 to 9months to prevent relapse after the remission of a depressive episode (Cleare et al. 2015).”
BackgroundInfluentialThe placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671 · cited 1×
“Although some authors differentiate between expectations and conditioning as different mechanisms involved in placebo and nocebo responses (Enck et al. 2013), it is not alwayspossible to clearly distinguish themsince learning also leads to certain expectations (Stewart-Williams and Podd 2004).”
BackgroundSelf-citationThe role of learning in nocebo and placebo effects
Colloca, L., Sigaudo, M., & Benedetti, F. (2008) · Pain · doi:10.1016/j.pain.2008.02.006 · Cited by 411
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323 · cited 2×
“All side effects occurring after the intake of an inert substance are not specific or attributable to the drugs’ pharmacokinetics (Schedlowski et al. 2015).”
BackgroundSelf-citationNonconscious activation of placebo and nocebo pain responses
Jensen, K. B., Kaptchuk, T. J., Kirsch, I., Raicek, J., Lindstrom, K. M., Berna, C., Gollub, R. L., Ingvar, M., & Kong, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202056109 · Cited by 305
How the number of learning trials affects placebo and nocebo responses
Colloca, L., Petrovic, P., Wager, T. D., Ingvar, M., & Benedetti, F. (2010) · Pain · doi:10.1016/j.pain.2010.08.007 · Cited by 300 · cited 2×
“tion trial suffices to induce nocebo effects, although effects are more stable after additional trials (Colloca et al. 2010).”
Background
Cited by
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Petrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309
“These same symptoms also frequently appear in studies of adverse effects reported by patients taking placebos (Rief et al. 2006).”
BackgroundSelf-citationKube, T., Glombiewski, J. A., & Rief, W. (2018) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000596 · Cited by 62
Self-citation
Metadata
- Authors
- Rheker, J., Winkler, A., Doering, B. K., & Rief, W.
- Venue
- Psychopharmacology
- Published
- 2016-11-02
- Volume
- 234
- Issue
- 3
- Pages
- 329-338
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2546588364
- Cited by
- 49
- References
- 17
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Learning to experience side effects after antidepressant intake – Results from a randomized, controlled, double-blind study. https://app.cochat.ai/papers/10.1007/s00213-016-4466-8
- The paper
- Rheker, J., Winkler, A., Doering, B. K., & Rief, W. (2017). Learning to experience side effects after antidepressant intake – Results from a randomized, controlled, double-blind study. Psychopharmacology. https://doi.org/10.1007/s00213-016-4466-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.